03/05
Headlines
FB Nasdaq FB Facebook

Biotech Bearish Stocks: Celsus Therapeutics (NASDAQ:CLTX), Reliv International (NASDAQ:RELV), Fate Therapeutics Inc (NASDAQ:FATE), CorMedix Inc. (NYSEMKT:CRMD)

John Meady02 mins

Celsus Therapeutics PLC (ADR) (NASDAQ:CLTX) major shareholder Sabby Management, Llc acquired 16,203 shares of Celsus Therapeutics PLC stock in a transaction dated Thursday, March 27th. The shares were purchased at an average price of $6.66 per share, for a total transaction of $107,911.98. Celsus Therapeutics PLC (ADR) (NASDAQ:CLTX) stock performance was -5.24% in last session…

Read More

Biotech Bullish Stocks: Merrimack Pharmaceuticals (NASDAQ:MACK), Sarepta Therapeutics (NASDAQ:SRPT), Northwest Biotherapeutics (NASDAQ:NWBO), Progenics Pharmaceuticals (NASDAQ:PGNX)

Mark DeFrance02 mins

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that it will present at the 2014 AACR Annual Meeting. The conference will take place on April 5-9, 2014 at the San Diego Convention Center in San Diego. Presentations will include a clinical pilot study evaluating the feasibility of using ferumoxytol* as an MRI imaging agent prior to MM-398 investigational…

Read More

Small Cap Active Runners: IAMGOLD (NYSE:IAG), Trina Solar (NYSE:TSL), AK Steel Holding Corporation (NYSE:AKS), The Medicines Company (NASDAQ:MDCO)

Kristen Barton02 mins

IAMGOLD Corporation (USA) (NYSE:IAG) announced that a Form 40-F report has been filed with the U.S. Securities and Exchange Commission, consisting of the 2013 annual audited financial statements, management discussion and analysis and the annual information form (‘AIF”). IAMGOLD Corp (USA) (NYSE:IAG) stock performance was -2.27% in last session and finished the day at $3.44….

Read More

Biotech Most Volatile: Cara Therapeutics Inc (NASDAQ:CARA), Prothena Corporation (NASDAQ:PRTA), CorMedix Inc. (NYSEMKT:CRMD), Stemline Therapeutics (NASDAQ:STML)

John Bellich02 mins

Cara Therapeutics Inc (NASDAQ:CARA) posted its quarterly earnings results on Thursday. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by $0.31. Cara Therapeutics Inc (NASDAQ:CARA) stock performance was 3.44% in last session and finished the day at $19.25. Traded volume was 234.6K shares in the last…

Read More

Biotech New Lows: Recro Pharma (NASDAQ:REPH), Ruthigen (NASDAQ:RTGN), Mediwound (NASDAQ:MDWD), Dicerna Pharmaceuticals (NASDAQ:DRNA)

Chris Lewis02 mins

On March 12, 2014, Recro Pharma, Inc (NASDAQ:REPH) completed its initial public offering (“IPO”). In relation to such IPO, the Company filed information reflected in a slide presentation as a free writing prospectus on February 13, 2014. Recro Pharma Inc (NASDAQ:REPH) stock performance was -4.64% in last session and finished the day at $6.98. Traded…

Read More

Investor’s Alert: Apple Inc. (NASDAQ:AAPL), Nokia Corporation (ADR) (NYSE:NOK), Tesla Motors Inc (NASDAQ:TSLA), Baidu Inc (ADR) (NASDAQ:BIDU)

Jayne Crisman02 mins

Apple Inc. (NASDAQ:AAPL) and Samsung return to federal court on Tuesday for opening statements in their latest patent battle, with the iPhone maker expected to present more detailed evidence in its attempt to win a US ban on sales of several Samsung smartphones. Apple Inc. (NASDAQ:AAPL) and Samsung Electronics Co Ltd have been litigating around…

Read More

Tech News

Tech Analysis & Market News

Skip to content ↓